QINGSONG HEALTH (02661) Announces February 2026 Monthly Return

Bulletin Express03-04

On 4 March 2026, QINGSONG HEALTH (02661) released its monthly return for the reporting period ended 28 February 2026. The authorized share capital remained unchanged at 500.00 million ordinary shares with a par value of USD 0.0001 each, totaling USD 50,000.

The total issued share capital also remained unchanged at 206.37 million ordinary shares with zero treasury shares. The company confirmed compliance with the applicable public float requirement of 25%. Further details indicated that 28.09 million share options under the 2017 Share Plan remained outstanding with no new grants, exercises, cancellations, or lapses in the month. There were no reported warrants, convertibles, or other issuance arrangements.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment